Institutional Investors Eye Drastic Measures as AbCellera Biologics Continues to Decline.
Trending News 🌥️ ABCELLERA ($NASDAQ:ABCL): Institutional investors are taking drastic measures due to the one-year losses of AbCellera Biologics Inc. [...]
AbCellera to Present Cutting-Edge T-Cell Engager Discovery Findings at AACR 2023
Trending News ☀️ ABCELLERA ($NASDAQ:ABCL): AbCellera Biologics will be presenting cutting-edge findings on their T-Cell Engager discovery at the upcoming [...]
Investors Ask: Is Now the Time to Buy AbCellera Biologics Stock After Closing at $10.52?
Trending News 🌥️ ABCELLERA ($NASDAQ:ABCL): AbCellera Biologics Inc. is a biotechnology company that uses artificial intelligence and machine learning to [...]
AbCellera Biologics Stock Closes 6.25% Higher, Reflecting Positive Sentiment
Trending News ☀️ ABCELLERA ($NASDAQ:ABCL): AbCellera Biologics Inc. is a biotechnology company that specializes in the discovery and development of [...]
Regeneron and AbCellera collaborate on second antibody program
Trending News 🌥️ ABCELLERA ($NASDAQ:ABCL): AbCellera Biologics Inc. is a Canadian biotechnology company that discovers, develops and manufactures antibody therapeutics [...]
